US Stocks Movers | Corcept Therapeutics Soars Nearly 21% Pre-market, Q2 Results Far Exceed Expectations

格隆汇2026/07/30 08:28

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Golden Ten Data July 30｜Corcept Therapeutics surged nearly 21% in pre-market trading, quoted at $112.264. The company's second-quarter revenue was $256 million, higher than $194 million in the same period last year. This revenue exceeded analysts' expectations of $219 million by 16.8%. Earnings per share were $0.36, above the expected $0.02.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

US Stocks Movers | Corcept Therapeutics Soars Nearly 21% Pre-market, Q2 Results Far Exceed Expectations

You may also like

Crypto prices